|
Sangamo BioSciences, Inc. |
Fyodor Urnov |
Strategic Partnership II |
A Treatment For Beta-thalassemia via High-Efficiency Targeted Genome Editing of Hematopoietic Stem Cells |
$6,374,150 |
|
University of California, San Francisco |
Susan Fisher |
Research Training II |
Training Program in Stem Cell Research |
$7,946,605 |
|
University of California, San Diego |
Eugene Yeo |
Basic Biology III |
Neural and general splicing factors control self-renewal, neural survival and differentiation |
$1,372,660 |
|
California State University, Fullerton |
Nilay Patel |
Bridges |
Stem Cell Training Program - A Bridge to Stem Cell Research |
$2,710,703 |
|
Beckman Research Institute of City of Hope |
Jiing-Kuan Yee |
Basic Biology III |
Use of human iPS cells to study spinal muscular atrophy |
$1,268,868 |
|
Stanford University |
Sean Wu |
Basic Biology III |
Elucidating Molecular Basis of Hypertrophic Cardiomyopathy with Human Induced Pluripotent Stem Cells |
$1,425,600 |
|
California State University, Long Beach |
Lisa Klig |
Bridges |
CIRM Stem Cell Research Biotechnology Training Program |
$3,042,698 |
|
University of California, Berkeley |
Song Li |
Basic Biology III |
Induced Pluripotent Stem Cells for Tissue Regeneration |
$1,341,064 |
|
University of California, San Diego |
Deborah Spector |
Basic Biology III |
Viral-host interactions affecting neural differentiation of human progenitors |
$1,372,660 |
|
California State University, Northridge |
Cindy Malone |
Bridges |
Bridges to Stem Cell Research |
$3,382,877 |
|
University of Southern California |
Robert Maxson |
Training Grant I-1 |
CIRM Stem Cell Biology Training Grant |
$3,158,532 |
|
University of California, Los Angeles |
Ali Nsair |
Basic Biology III |
Characterization and Engineering of the Cardiac Stem Cell Niche |
$1,181,306 |
|
Beckman Research Institute of City of Hope |
Michael Barish |
Research Training II |
Research Training Program in Stem Cell Biology |
$2,500,143 |
|
The Parkinson's Institute |
R. Jeremy Nichols |
Basic Biology III |
Understanding the role of LRRK2 in iPSC cell models of Parkinson's Disease |
$1,482,822 |
|
California State University, Sacramento |
Jane Bruner |
Bridges |
Strengthening the Pipeline of Masters-level Scientific and Laboratory Personnel in Stem Cell Research |
$2,773,463 |
|
University of California, San Diego |
Anirvan Ghosh |
Basic Biology III |
Investigation of synaptic defects in autism using patient-derived induced pluripotent stem cells |
$1,391,400 |
|
Stanford University |
Renee Reijo Pera |
Basic Biology III |
Correlated time-lapse imaging and single cell molecular analysis of human embryo development |
$1,425,600 |
|
California State University, San Bernardino |
Nicole Bournias-Vardiabasis |
Bridges |
Bridges to Stem Cell Research |
$2,607,705 |
|
Scripps Research Institute |
Joel Gottesfeld |
Basic Biology III |
Triplet Repeat Instability in Human iPSCs |
$1,755,861 |
|
The J. David Gladstone Institutes |
Robert Mahley |
Research Training II |
CIRM Scholars Program |
$5,111,047 |
|
Stanford University |
Michael Clarke |
Basic Biology III |
USP16 controls stem cell number: implications for Down Syndrome |
$1,425,600 |
|
California State University, San Marcos |
Bianca Mothe |
Bridges |
CIRM Bridges to the Stem Cell Research Training Grant |
$3,613,311 |
|
University of California, Los Angeles |
William Lowry |
Basic Biology III |
Molecular determinants of accurate differentiation from human pluripotent stem cells |
$1,354,230 |
|
Stanford University |
Joanna Wysocka |
Basic Biology III |
Enhancer-mediated gene regulation during early human embryonic development |
$1,425,600 |
|
City College Of San Francisco |
Carin Zimmerman |
Bridges |
Stem Cell Training Enhancement Program |
$2,454,307 |
|
University of California, Los Angeles |
Shuo Lin |
Basic Biology III |
Etsrp/ER71 mediated stem cell differentiation into vascular lineage |
$1,382,400 |
|
University of California, Los Angeles |
Kathrin Plath |
Basic Biology III |
Discovery of mechanisms that control epigenetic states in human reprogramming and pluripotent cells |
$1,364,598 |
|
Humboldt State University |
Jacob Varkey |
Bridges |
CIRM Bridges to Stem Cell Research Certificate Program |
$3,497,510 |
|
Scripps Research Institute |
Kristin Baldwin |
Basic Biology III |
Identifying sources of mutation in human induced pluripotent stem cells by whole genome sequencing |
$1,755,864 |
|
University of California, San Francisco |
Harold Bernstein |
Basic Biology III |
Phenotypic Analysis of Human ES Cell-Derived Muscle Stem Cells |
$1,381,296 |
|
Pasadena City College |
Pamela Eversole-Cire |
Bridges |
Bridges to Stem Cell Research |
$3,609,138 |
|
University of California, San Francisco |
John Murnane |
Basic Biology III |
Genomic instability during culturing of human embryonic stem cells |
$1,074,355 |
|
San Diego State University |
Ralph Feuer |
Bridges |
CIRM Stem Cell Internship Program |
$3,597,177 |
|
University of California, Berkeley |
Michael Rape |
Basic Biology III |
Ubiquitin-dependent control of hESC self-renewal and expansion |
$1,364,091 |
|
University of California, San Diego |
Charles King |
Basic Biology III |
Biological relevance of microRNAs in hESC differentiation to endocrine pancreas |
$1,313,649 |
|
San Francisco State University |
Carmen Domingo |
Bridges |
Bridges to Stem Cell Research |
$3,594,705 |
|
University of California, San Diego |
Kun Zhang |
Basic Biology III |
Functional characterization of mutational load in nuclear reprogramming and differentiation |
$1,382,140 |
|
San Jose State University |
Tzvia Abramson |
Bridges |
Stem Cell Internships for Laboratory-based Learning (SCILL) |
$3,614,907 |
|
University of California, San Diego |
Farah Sheikh |
Basic Biology III |
Molecular Mechanisms Underlying Human Cardiac Cell Junction Maturation and Disease Using Human iPSC |
$1,341,955 |
|
Berkeley City College |
Barbara Des Rochers |
Bridges |
Specialty in Stem Cell Biology |
$2,450,257 |
|
University of California, San Diego |
David Cheresh |
Basic Biology III |
Molecular basis of human ES cell neurovascular differentiation and co-patterning |
$1,361,448 |
|
California Polytechnic State University, San Luis Obispo |
Trevor Cardinal |
Bridges |
Masters of Science Specialization in Stem Cell Technology |
$3,020,182 |
|
University of California, San Diego |
Binhai Zheng |
Basic Biology III |
Generation and characterization of corticospinal neurons from human embryonic stem cells |
$1,355,063 |
|
University of California, Los Angeles |
Yi Sun |
Basic Biology III |
Studying neurotransmission of normal and diseased human ES cell-derived neurons in vivo |
$1,382,400 |
|
California State Polytechnic University, Pomona |
Jill Adler-Moore |
Bridges |
Collaborative CIRM Bridges Program to Enhance Stem Cell Research Training and Education |
$3,008,975 |
|
Buck Institute for Age Research |
David Greenberg |
Research Training II |
CIRM Research Training Program in Stem Cells and Aging |
$3,178,692 |
|
The J. David Gladstone Institutes |
Deepak Srivastava |
Basic Biology III |
Mechanisms of Direct Cardiac Reprogramming |
$1,708,560 |
|
California State University, Channel Islands |
Ching-Hua Wang |
Bridges |
Curriculum Development and Implementation of Stem Cell Technology and Laboratory Management Emphasis in an Established MS Biotechnology and Bioinformatics Program at (REDACTED) and Co-development of a GE Course on Stem Cel |
$3,614,553 |
|
University of California, Los Angeles |
Gay Crooks |
Basic Biology III |
Forming the Hematopoietic Niche from Human Pluripotent Stem Cells |
$1,375,983 |
|
University of California, San Francisco |
Long-cheng Li |
New Cell Lines |
Induction of pluripotent stem cells by small RNA-guided transcriptional activation |
$1,375,144 |
|
Beckman Research Institute of City of Hope |
Tiziano Barberi |
New Faculty I |
Skeletal muscle development from hESC and its in vivo applications in animal models of muscular dystrophy |
$1,623,064 |
|
Stanford University |
Michael Longaker |
New Cell Lines |
Derivation and analysis of pluripotent stem cell lines with inherited TGF-b mediated disorders from donated IVF embryos and reprogrammed adult skin fibroblasts |
$1,424,412 |
|
Stanford University |
Anne Brunet |
New Faculty I |
Molecular mechanisms involved in adult neural stem cell maintenance |
$2,348,520 |
|
University of California, San Francisco |
Miguel Ramalho-Santos |
New Cell Lines |
Somatic cell age and memory in the generation of iPS cells |
$1,307,201 |
|
University of California, Davis |
Chong-Xian Pan |
New Faculty I |
Combinatorial Chemistry Approaches to Develop LIgands against Leukemia Stem Cells |
$2,567,397 |
|
Stanford University |
Renee Reijo Pera |
New Cell Lines |
Derivation and comparative analysis of human pluripotent ESCs, iPSCs and SSCs: Convergence to an embryonic phenotype |
$1,410,042 |
|
University of California, San Diego |
David Traver |
New Faculty I |
Genetic dissection of mesodermal commitment to the hematopoietic fates. |
$2,185,369 |
|
The J. David Gladstone Institutes |
Sheng Ding |
New Cell Lines |
Derivation of New ICM-stage hESCs |
$1,719,468 |
|
The Salk Institute for Biological Studies |
Lei Wang |
New Faculty I |
Genetic Encoding Novel Amino Acids in Embryonic Stem Cells for Molecular Understanding of Differentiation to Dopamine Neurons |
$2,626,937 |
|
University of California, Irvine |
Leslie Thompson |
New Cell Lines |
New Cell Lines for Huntington's Disease |
$1,369,800 |
|
Stanford University |
Howard Chang |
New Faculty I |
Noncoding RNAs in Cell Fate Determination |
$3,203,926 |
|
University of California, Los Angeles |
Siavash Kurdistani |
New Faculty I |
Epigenetics in cancer stem cell initiation and clinical outcome prediction |
$3,238,450 |
|
University of California, Los Angeles |
Zack Jerome |
New Cell Lines |
Generation of clinical grade human iPS cells |
$1,382,400 |
|
Stanford University |
Renee Reijo Pera |
Comprehensive Grant |
Human oocyte development for genetic, pharmacological and reprogramming applications |
$2,469,104 |
|
University of California, Santa Cruz |
Camilla Forsberg |
New Faculty I |
Mechanisms of Stem Cell Fate Decisions |
$2,330,111 |
|
University of California, Los Angeles |
Hanna Mikkola |
New Faculty I |
Mechanisms of Hematopoietic stem cell Specification and Self-Renewal |
$2,286,900 |
|
Sanford-Burnham Medical Research Institute |
Zhuohua Zhang |
New Cell Lines |
Derivation of Parkinson's Disease Coded-Stem Cells (PD-SCs) |
$1,589,760 |
|
University of California, Merced |
Jennifer Manilay |
New Faculty I |
Enhancing Survival of Embryonic Stem Cell-Derived Grafts by Induction of Immunological Tolerance |
$1,581,056 |
|
University of Southern California |
Mohammad Pashmforoush |
New Faculty I |
Transcriptional Regulation of Cardiac Pacemaker Cell Progenitors |
$3,149,806 |
|
University of California, Davis |
Mark Zern |
Comprehensive Grant |
An in vitro and in vivo comparison among three different human hepatic stem cell populations |
$2,504,614 |
|
Stanford University |
Julie Baker |
New Cell Lines |
Derivation of hESC Lines with Disease Lesions |
$1,424,412 |
|
Stanford University |
Joanna Wysocka |
New Faculty I |
Trithorax and Polycomb methyltransferase complexes in cell fate determination. |
$2,374,020 |
|
University of California, Irvine |
Andrew Putnam |
New Faculty I |
A Novel Engineered Niche to Explore the Vasculogenic Potential of Embryonic Stem Cells |
$2,108,683 |
|
Stanford University |
Michele Calos |
New Cell Lines |
Safe, efficient creation of human induced pluripotent stem cells without the use of retroviruses |
$1,406,875 |
|
Scripps Research Institute |
Kristin Baldwin |
New Faculty I |
Generating pluripotent cell lines from neurons. |
$2,803,375 |
|
Western University of Health Sciences |
Douglas Ethell |
New Faculty I |
ES-Derived Cells for the Treatment of Alzheimer's Disease |
$2,120,833 |
|
University of California, Los Angeles |
Amander Clark |
New Cell Lines |
Generation of Pluripotent Cell Lines from Human Embryos |
$1,177,648 |
|
The Salk Institute for Biological Studies |
Fred Gage |
Comprehensive Grant |
Molecular and Cellular Transitions from ES Cells to Mature Functioning Human Neurons |
$2,879,210 |
|
University of California, Los Angeles |
Dana Jones |
New Faculty I |
Characterization of mechanisms regulating de-differentiation and the re-acquisition of stem cell identity |
$2,675,234 |
|
The J. David Gladstone Institutes |
Sheng Ding |
New Faculty I |
Reprogramming of human somatic cells back to pluripotent embryonic stem cells |
$2,943,375 |
|
University of California, Davis |
Paul Knoepfler |
New Faculty II |
Molecular mechanisms governing hESC and iPS cell self-renewal and pluripotency |
$2,158,161 |
|
University of California, San Francisco |
Mark Anderson |
Transplantation Immunology |
Stem cell differentiation to thymic epithelium for inducing tolerance to stem cells
|
$1,314,090 |
|
The J. David Gladstone Institutes |
Bruce Conklin |
New Cell Lines |
Induced Pluripotent Stem Cells for Cardiovascular Diagnostics |
$1,708,560 |
|
University of California, Berkeley |
Irina Conboy |
New Faculty I |
Identification of hESC-mediated molecular mechanism that positively regulates the regenerative capacity of post-natal tissues |
$2,246,020 |
|
University of California, Davis |
Alice Tarantal |
Comprehensive Grant |
Preclinical Model for Labeling, Transplant, and In Vivo Imaging of Differentiated Human Embryonic Stem Cells |
$2,257,040 |
|
University of California, San Diego |
Steve Dowdy |
New Cell Lines |
Protein transduction of transcription factors: a non-genetic approach to generate new pluripotent cell lines from human skin. |
$1,387,800 |
|
University of California, Santa Cruz |
Bin Chen |
New Faculty I |
Molecular mechanisms of neural stem cell differentiation in the developing brain |
$2,200,715 |
|
University of California, San Francisco |
Susan Fisher |
New Cell Lines |
Optimization of Human Embryonic Stem Cell Derivation Techniques and Production/Distribution of GMP-Grade Lines |
$1,383,419 |
|
Stanford University |
Karl Deisseroth |
New Faculty I |
Bioengineering technology for fast optical control of differentiation and function in stem cells and stem cell progeny |
$3,154,719 |
|
The J. David Gladstone Institutes |
Robert Farese |
New Cell Lines |
Establishment of Frontotemporal Dementia Patient-Specific Induced Pluripotent Stem (iPS) Cell Lines with Defined Genetic Mutations |
$1,708,560 |
|
University of California, Los Angeles |
Kathrin Plath |
New Faculty I |
In vitro reprogramming of mouse and human somatic cells to an embryonic state |
$2,229,427 |
|
University of Southern California |
Martin Pera |
New Cell Lines |
New Technology ForThe Derivation of Human Pluripotent Stem Cell Lines For Clinical Use |
$1,387,508 |
|
The Salk Institute for Biological Studies |
Fred Gage |
New Cell Lines |
Development of Induced Pluripotent Stem Cells for Modeling Human Disease |
$1,737,720 |
|
University of Southern California |
Songtao Shi |
New Faculty I |
Oral and Craniofacial Reconstruction Using Mesenchymal Stem Cells |
$3,428,464 |
|
The J. David Gladstone Institutes |
Kevin Parker |
Research Leadership 12 |
Engineering Cardiac Tissue for Regeneration and Drug Development |
$7,480,036 |
|
Stanford University |
Hiromitsu Nakauchi |
Research Leadership 12 |
Generation of functional cells and organs from iPSCs |
$6,228,068 |
|
University of California, Santa Cruz |
Richard Gregory |
Research Leadership 12 |
MicroRNA Regulation in Stem Cells, Development, and Disease |
$5,380,705 |
|
University of California, San Diego |
Eric Ahrens |
Research Leadership 12 |
Molecular Imaging for Stem Cell Science and Clinical Application |
$6,443,455 |
|
Cedars-Sinai Medical Center |
Barry Stripp |
Research Leadership 12 |
Epithelial progenitors and the stromal niche as therapeutic targets in lung disease |
$4,841,830 |
|
Capricor, Inc |
Rachel Smith |
Disease Team Therapy Development - Research |
Allogeneic Cardiac-Derived Stem Cells for Patients Following a Myocardial Infarction |
$19,782,136 |